Systems biology analysis of G protein and MAP kinase signaling in yeast

Oncogene

Volumn 26, Issue 22, 2007, Pages 3254-3266

  Hao, N ^a   Behar, M ^b   Elston, T C ^a   Dohlman, H G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Desensitization; Genetics; Mitogen activated protein kinases; Modeling; Systems biology; Yeast

Indexed keywords

CEP 1347; GUANINE NUCLEOTIDE BINDING PROTEIN; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CELL FUNCTION; CLINICAL TRIAL; DESENSITIZATION; DIABETES MELLITUS; DRUG SYNTHESIS; DRUG TARGETING; FUNGAL GENETICS; HUMAN; HYPERTENSION; MATHEMATICAL MODEL; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR MODEL; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; STROKE; SYSTEMS BIOLOGY; YEAST;

GTP-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SYSTEMS BIOLOGY;

EID: 34248575122     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210416     Document Type: Review

References (80)

1. Alon U, Surette MG, Barkai N, Leibler S. (1999). Robustness in bacterial chemotaxis. Nature 397: 168-171.
2. Alon U. (2006). An Introduction to Systems Biology. Chapman & Hall: London ISBN 1-58488-642-0.
3. Apanovitch DM, Iiri T, Karasawa T, Bourne HR, Dohlman HG. (1998a). Second site suppressor mutations of a GTPase-deficient G-protein α- subunit. Selective inhibition of βγ-mediated signaling. J Biol Chem 273: 28597-28602.
4. Apanovitch DM, Slep KC, Sigler PB, Dohlman HG. (1998b). Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Gα protein pair in yeast. Biochemistry 37: 4815-4822.
5. Barnes DJ, Melo JV. (2003). Management of chronic myeloid leukemia: targets for molecular therapy. Semin Hematol 40: 34-49.
6. Bhalla US, Ram PT, Iyengar R. (2002). MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297: 1018-1023.
7. Bornheimer SJ, Maurya MR, Farquhar MG, Subramaniam S. (2004). Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction. Proc Natl Acad Sci USA 101: 15899-15904.
8. Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC. (1993). An osmosensing signal transduction pathway in yeast. Science 259: 1760-1763.
9. Chan RK, Otte CA. (1982a). Isolation and genetic analysis of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and α factor pheromones. Mol Cell Biol 2: 11-20.
10. Chan RK, Otte CA. (1982b). Physiological characterization of Saccharomyces cerevisiae mutants supersensitive to G1 arrest by a factor and α factor pheromones. Mol Cell Biol 2: 21-29.
11. Chasse SA, Dohlman HG. (2003). RGS proteins: G protein-coupled receptors meet their match. Assay Drug Dev Technol 1: 357-364.
12. Chasse SA, Flanary P, Parnell SC, Hao N, Cha JY, Siderovski DP et al. (2006). Genome-scale analysis reveals Sst2 as the principal regulator of mating pheromone signaling in the yeast Saccharomyces cerevisiae. Eukaryot Cell 5: 330-346.
13. Dohlman HG, Thorner JW. (2001). Regulation of G protein-initiated signal transduction in yeast: Paradigms and principles. Annu Rev Biochem 70: 703-754.
14. Dohlman HG, Apaniesk D, Chen Y, Song J, Nusskern D. (1995). Inhibition of G-protein signaling by dominant gain-of-function mutations in Sst2p, a pheromone desensitization factor in Saccharomyces cerevisiae. Mol Cell Biol 15: 3635-3643.
15. Dohlman HG, Song J, Ma D, Courchesne WE, Thorner J. (1996). Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces cerevisiae: expression, localization, and genetic interaction and physical association with Gpa1 (the G-protein α subunit). Mol Cell Biol 16: 5194-5209.
16. Dohlman HG. (2002). Diminishing returns. Nature 418: 591.
17. Farfel Z, Bourne HR, Iiri T. (1999). The expanding spectrum of G protein diseases. N Engl J Med 340: 1012-1020.
18. Ferrell JE, Xiong W. (2001). Bistability in cell signaling: how to make continuous processes discontinuous, and reversible processes irreversible? Chaos 11: 227-236.
19. Force T, Kuida K, Namchuk M, Parang K, Kyriakis JM. (2004). Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease. Circulation 109: 1196-1205.
20. Garrison TR, Zhang Y, Pausch M, Apanovitch D, Aebersold R, Dohlman HG. (1999). Feedback phosphorylation of an RGS protein by MAP kinase in yeast. J Biol Chem 274: 36387-36391.
21. Gelperin DM, White MA, Wilkinson ML, Kon Y, Kung LA, Wise KJ et al. (2005). Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev 19: 2816-2826.
22. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N et al. (2003). Global analysis of protein expression in yeast. Nature 425: 737-741.
23. Gibbs JB, Oliff A. (1994). Pharmaceutical research in molecular oncology. Cell 79: 193-198.
24. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H et al. (1996). Life with 6000 genes [see comments]. Science 274: 54656 3-7.
25. Gold SJ, Ni YG, Dohlman HG, Nestler EJ. (1997). Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037.
26. Goldbeter A, Koshland Jr DE. (1981). An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci USA 78: 6840-6844.
27. Guo M, Aston C, Burchett SA, Dyke C, Fields S, Rajarao SJ et al. (2003). The yeast G protein a subunit Gpa1 transmits a signal through an RNA binding effector protein Scp160. Mol Cell 12: 517-524.
28. Gutkind JS. (1998). The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839-1842.
29. Hao N, Behar M, Parnell SC, Torres MP, Borchers CH, Elston TC et al. (2007). Experimental and computational analysis of feedback inhibition of the Sho1 osmotic stress-response pathway. Curr Biol (in press).
30. Hao N, Yildirim N, Wang Y, Elston TC, Dohlman HG. (2003). Regulators of G protein signaling and transient activation of signaling: experimental and computational analysis reveals negative and positive feedback controls on G protein activity. J Biol Chem 278: 46506-46515.
31. Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: New York ISBN 0-07-135469-7.
32. Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. (1997). Integrating genetic approaches into the discovery of anticancer drugs. Science 278: 1064-1068.
33. Heinrich R, Neel BG, Rapoport TA. (2002). Mathematical models of protein kinase signal transduction. Mol Cell 9: 957-970.
34. Hohmann S. (2002). Osmotic stress signaling and osmoadaptation in yeasts. Microbiol Mol Biol Rev 66: 300-372.
35. Hornberg JJ, Bruggeman FJ, Binder B, Geest CR, de Vaate AJ, Lankelma J et al. (2005). Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. FEBS J 272: 244-258.
36. Huang CY, Ferrell Jr JE. (1996). Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 93: 10078-10083.
37. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS et al. (2003). Global analysis of protein localization in budding yeast. Nature 425: 686-691.
38. Jacoby T, Flanagan H, Faykin A, Seto AG, Mattison C, Ota I. (1997). Two protein-tyrosine phosphatases inactivate the osmotic stress response pathway in yeast by targeting the mitogen-activated protein kinase, Hog1. J Biol Chem 272: 17749-17755.
39. Johnson GL, Dohlman HG, Graves LM. (2005). MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr Opin Chem Biol 9: 325-331.
40. Kenakin T. (2004). Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25: 186-192.
41. Kholodenko BN. (2000). Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem 267: 1583-1588.
42. Klipp E, Nordlander B, Kruger R, Gennemark P, Hohmann S. (2005). Integrative model of the response of yeast to osmotic shock. Nat Biotechnol 23: 975-982.
43. Kofahl B, Klipp E. (2004). Modelling the dynamics of the yeast pheromone pathway. Yeast 21: 831-850.
44. Komarova NL, Zou X, Nie Q, Bardwell L. (2005). A theoretical framework for specificity in cell signaling. Mol Syst Biol 1: 0023.
45. Kumar S, Boehm J, Lee JC. (2003). p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2: 717-726.
46. Lin FT, Miller WE, Luttrell LM, Lefkowitz RJ. (1999). Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases [in process citation]. J Biol Chem 274: 15971-15974.
47. Marinissen MJ, Gutkind JS. (2001). G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376.
48. Markevich NI, Hoek JB, Kholodenko BN. (2004). Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades. J Cell Biol 164: 353-359.
49. Marshall CJ. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
50. Martin H, Flandez M, Nombela C, Molina M. (2005). Protein phosphatases in MAPK signalling: we keep learning from yeast. Mol Microbiol 58: 6-16.
51. Martzen MR, McCraith SM, Spinelli SL, Torres FM, Fields S, Grayhack EJ et al. (1999). A biochemical genomics approach for identifying genes by the activity of their products. Science 286: 1153-1155.
52. Morrison DK, Davis RJ. (2003). Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 19: 91-118.
53. Neubig RR, Siderovski DP. (2002). Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1: 187-197.
54. Neves SR, Ram PT, Iyengar R. (2002). G protein pathways. Science 296: 1636-1639.
55. Ogier-Denis E, Pattingre S, El Benna J, Codogno P. (2000). Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275: 39090-39095.
56. Parnell SC, Marotti Jr LA, Kiang L, Torres MP, Borchers CH, Dohlman HG. (2005). Phosphorylation of the RGS protein Sst2 by the MAP kinase Fus3 and use of Sst2 as a model to analyze determinants of substrate sequence specificity. Biochemistry 44: 8159-8166.
57. Pitcher JA, Tesmer JJ, Freeman JL, Capel WD, Stone WC, Lefkowitz RJ. (1999). Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem 274: 34531-34534.
58. Roberts CJ, Nelson B, Marton MJ, Stoughton R, Meyer MR, Bennett HA et al. (2000). Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287: 873-880.
59. Roman DL, Talbot JN, Roof RA, Sunahara RK, Traynor JR, Neubig RR. (2006). Identification of small molecule inhibitors of Regulator of G-protein Signaling 4 (RGS4) using a high throughput flow cytometry protein interaction assay (FCPIA). Mol Pharmacol 71: 169-175.
60. Sabbagh Jr W, Flatauer LJ, Bardwell AJ, Bardwell L. (2001). Specificity of MAP kinase signaling in yeast differentiation involves transient versus sustained MAPK activation. Mol Cell 8: 683-691.
61. Sasagawa S, Ozaki Y, Fujita K, Kuroda S. (2005). Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 7: 365-373.
62. Schaber J, Kofahl B, Kowald A, Klipp E. (2006). A modelling approach to quantify dynamic crosstalk between the pheromone and the starvation pathway in baker's yeast. FEBS J 273: 3520-3533.
63. Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G. (2002). Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 20: 370-375.
64. Sebolt-Leopold JS, English JM. (2006). Mechanisms of drug inhibition of signalling molecules. Nature 441: 457-462.
65. Shao D, Zheng W, Qiu W, Ouyang Q, Tang C. (2006). Dynamic studies of scaffold-dependent mating pathway in yeast. Biophys J 91: 3986-4001.
66. Shenoy SK, Lefkowitz RJ. (2005). Seven-transmembrane receptor signaling through beta-arrestin. Sci STKE 2005: cm10.
67. Slessareva JE, Routt SM, Temple B, Bankaitis VA, Dohlman HG. (2006). Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome. Cell 126: 191-203.
68. Somsen OJ, Siderius M, Bauer FF, Snoep JL, Westerhoff HV. (2002). Selectivity in overlapping MAP kinase cascades. J Theor Biol 218: 343-354.
69. Spiegel AM. (2000). G protein defects in signal transduction. Horm Res 53: 17-22.
70. Sprang SR. (1997). G protein mechanisms: insights from structural analysis. Annu Rev Biochem 66: 639-678.
71. Tyson JJ, Chen KC, Novak B. (2003). Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15: 221-231.
72. Wang X, Hao N, Dohlman HG, Elston TC. (2006). Bistability, stochasticity, and oscillations in the mitogen-activated protein kinase cascade. Biophys J 90: 1961-1978.
73. Wang Y, Dohlman HG. (2002). Pheromone-dependent ubiquitination of the mitogen-activated protein kinase kinase Ste7. J Biol Chem 277: 15766-15772.
74. Wang Y, Ge Q, Houston D, Thorner J, Errede B, Dohlman HG. (2003). Regulation of Ste7 ubiquitination by Ste11 phosphorylation and the Skp1-Cullin-F-box complex. J Biol Chem 278: 22284-22289.
75. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B et al. (1999). Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906.
76. Wurgler-Murphy SM, Maeda T, Witten EA, Saito H. (1997). Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases. Mol Cell Biol 17: 1289-1297.
77. Xiong W, Ferrell Jr JE. (2003). A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature 426: 460-465.
78. Yi TM, Huang Y, Simon MI, Doyle J. (2000). Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci USA 97: 4649-4653.
79. Yi TM, Kitano H, Simon MI. (2003). A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc Natl Acad Sci USA 100: 10764-10769.
80. Zhong H, Wade SM, Woolf PJ, Linderman JJ, Traynor JR, Neubig RR. (2003). A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protien-mediated kinetic scaffolding. J Biol Chem 278: 7278-7284.